Personalized Medicine for Moms and Kids Using Genetic Information
Supporting Precision Medicine for Maternal and Pediatric Care through Pharmacogenomics Research
This project aims to make sure medicines work best for children and pregnant women by understanding how their genes affect drug responses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11170758 on NIH RePORTER |
What this research studies
Many medicines are prescribed without fully knowing how a person's unique genes might change how the drug works, especially for children and pregnant women. This project wants to fill these gaps by looking at genetic information and how it relates to drug effects in these groups. We will also talk with diverse families to understand their thoughts and feelings about using genetic information for medicine choices. The goal is to make sure that personalized medicine, based on your genes, is safe and effective for everyone.
Who could benefit from this research
Good fit: Ideal candidates for this work include children with chronic diseases and pregnant women who may be interested in understanding how their genes affect medication.
Not a fit: Patients who are not children or pregnant women, or those without chronic conditions, may not directly benefit from this specific project's findings.
Why it matters
Potential benefit: If successful, this work could lead to safer and more effective medication choices for children and pregnant women, reducing side effects and improving treatment outcomes.
How similar studies have performed: While pharmacogenomics is a growing field, there are limited specific data for children and pregnant women, making this approach novel and crucial for these populations.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Van Driest, Sara Lynn — Vanderbilt University Medical Center
- Study coordinator: Van Driest, Sara Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.